T2 Biosystems Inc. (TTOO)
OTC: TTOO
· Real-Time Price · USD
0.13
0.01 (8.79%)
At close: Apr 04, 2025, 3:42 PM
T2 Biosystems Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -10.12M | -8.96M | -13.53M | -10.34M | -15.43M | -6.35M | -17.96M | -10.1M | -17.38M | -18.03M | -16.5M | -12.14M | -13.96M | -12.47M | -10.66M |
Depreciation & Amortization | 59K | 62K | 64K | 74K | 262K | 267K | 256K | 572K | 570K | 549K | 580K | 556K | 584K | 587K | 811K |
Stock-Based Compensation | 228K | 196K | 1.59M | 728K | 877K | 913K | 1.83M | 1.03M | 1.37M | 1.53M | 2.55M | 1.47M | 2.47M | 1.84M | 1.31M |
Other Working Capital | -2.16M | 500K | -932K | -476K | -1.89M | 484K | -2.39M | -133K | -89K | 676K | -1.41M | -45K | 838K | -24K | -1.73M |
Other Non-Cash Items | 2.61M | -629K | 2.17M | 1.57M | 623K | 856K | 3.61M | -210K | 592K | 2.19M | 543K | 1.02M | 992K | 972K | 953K |
Deferred Income Tax | n/a | n/a | n/a | -923K | 3.26M | -8.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -193K | -831K |
Change in Working Capital | 968K | 93K | -593K | -523K | -2.99M | 138K | -670K | -1.63M | -1.06M | 3.81M | -1.62M | -744K | 193K | -1.33M | -289K |
Operating Cash Flow | -6.25M | -9.24M | -11.68M | -9.42M | -13.39M | -12.39M | -12.94M | -10.33M | -15.9M | -9.96M | -14.44M | -9.84M | -9.73M | -10.6M | -8.71M |
Capital Expenditures | n/a | n/a | n/a | -26K | -13K | -33K | -120K | -36K | -126K | -148K | -29K | -199K | 42K | -106K | -197K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10M | n/a | 10M | n/a | 12.5M | 2.75M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10M | n/a | 10M | n/a | 12.5M | 2.75M |
Investing Cash Flow | n/a | n/a | n/a | -26K | -13K | -33K | -120K | -36K | -126K | 9.85M | -29K | 9.8M | 42K | 12.39M | 2.55M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 4.09M | 10K | -1K | 17K | -62K | 2K | n/a | 26K | 299K | 127K | -230K | 239K | 24K | 251K | 53K |
Financial Cash Flow | 4.09M | 7.28M | 2.2M | 812K | 21.64M | 18.39M | 11.85M | 748K | 23.18M | 3.92M | 1.2M | 239K | 24K | 20.22M | 53K |
Net Cash Flow | -1.61M | -1.96M | -9.48M | -8.63M | 8.23M | 5.97M | -1.21M | -9.62M | 7.15M | 3.81M | -13.27M | 198K | -9.66M | 22.02M | -6.1M |
Free Cash Flow | -6.25M | -9.24M | -11.68M | -9.44M | -13.41M | -12.42M | -13.06M | -10.37M | -16.03M | -10.1M | -14.47M | -10.04M | -9.69M | -10.7M | -8.9M |